Company Data
Tempest Therapeutics Inc.
Ticker
TPST
Current Price
$2.0161 27.6%
Market Cap
$28.9M
Price Target
Refer to Report
Volume
1.6M
52wk Range
$1.5 - $12.23
Overview
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.